Reuters logo
3 个月前
BRIEF-Keryx Biopharmaceuticals says additional medicare Part D plan sponsor has added auryxia to plan formularies, effective June 1
2017年5月1日 / 中午12点26分 / 3 个月前

BRIEF-Keryx Biopharmaceuticals says additional medicare Part D plan sponsor has added auryxia to plan formularies, effective June 1

1 分钟阅读

May 1 (Reuters) - Keryx Biopharmaceuticals Inc

* Keryx Biopharmaceuticals - additional medicare Part D plan sponsor has added auryxia to medicare Part D plan formularies, effective June 1, 2017

* Keryx Biopharmaceuticals Inc - Auryxia's formulary status at new Part D plan sponsor is effective for remainder of 2017 and full year 2018

* Keryx Biopharmaceuticals - seeking label expansion for ferric citrate to include treatment of iron deficiency anemia in adults with non-dialysis dependent ckd

* Keryx Biopharmaceuticals - supplemental new drug application under review by FDA, with PDUFA target action date of November 6, 2017 for completion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below